Mukund Paravasthu
Chief Operating Officer · NovoCure Ltd
- 2024
- Mar 5, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Mukund Paravasthu files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- William F. Doyle - $933K in NVCR purchases and sales in the last 12 months
- Frank X. Leonard - $920K in NVCR purchases and sales in the last 12 months
- Uri Weinberg - $232K in NVCR purchases and sales in the last 12 months
- Christoph Brackmann - $85K in NVCR purchases and sales in the last 12 months
- Jeryl L. Hilleman - $46K in NVCR purchases and sales in the last 12 months
- Timothy J. Scannell - $46K in NVCR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Mukund Paravasthu?
Mukund Paravasthu is a corporate insider, tracked as Chief Operating Officer of NovoCure Ltd (NVCR). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Mukund Paravasthu last file a Form 4?
The most recent primary Form 4 on record is dated 5 March 2026, one of 5 filings going back to 2024.
Has Mukund Paravasthu been buying or selling stock?
Recorded transactions: 0 open-market purchases and 6 open-market sales ($697K) across all tracked filings.
